Inventor
YOUNGMAN MARK
US11 patents
⚠️ This page may combine multiple inventors who share the name “YOUNGMAN MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
3 patentsUS6984647B2Jan 10, 2006
Aminotetralin-derived urea modulators of vanilloid VR1 receptor
JANSSEN PHARMACEUTICA NV15 citations91
US7183411B2Feb 27, 2007
Naphthol, quinoline and isoquinoline-derived urea modulators of vanilloid VR1 receptor
JANSSEN PHARMACEUTICA NV7 citations72
US7678812B2Mar 16, 2010
Aminotetralin-derived urea modulators of vanilloid VR1 receptor
JANSSEN PHARMACEUTICA NV5 citations61
PURDUE PHARMA LP
3 patentsUS9656968B2May 23, 2017
Pyrimidines as sodium channel blockers
PURDUE PHARMA LP3 citations71
US9902726B2Feb 27, 2018
Pyridone-sulfone morphinan analogs as opioid receptor ligands
PURDUE PHARMA LP0 citations40
US9862726B2Jan 9, 2018
Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans
PURDUE PHARMA LP0 citations40
ORTHO MCNEIL PHARM INC
2 patentsUS6380224B1Apr 30, 2002
Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
ORTHO MCNEIL PHARM INC46 citations92
US7071195B2Jul 4, 2006
Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
ORTHO MCNEIL PHARM INC2 citations62